Mergers & Acquisitions Mergers & Acquisitions

Elanco, Bayer say most players CADE queried are positive or neutral about their deal

By Ana Paula Candil
  • 09 Apr 2020 16:16
  • 09 Apr 2020 16:16
Elanco Animal Health and Bayer have told the Brazilian competition authority that a market inquiry conducted by the agency has shown that their deal won't harm competition. 

The parties said that most of the 63 players who have responded to the agency so far presented neutral or positive opinions about Elanco’s planned buyout

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News